Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Sanuwave Health Inc. (SNWV) had Revenue of $9.62M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$9.62M
Net Income	$-1.44M
Cost of Goods Sold	$2.19M
Gross Profit	$7.43M
Operating Expenses	$10.74M
Operating Income	$-1.12M
Non-Operating Income/Expense	$-0.32M
Pre-Tax Income	$-1.44M
Normalized Pre-Tax Income	$-1.44M
Income after Taxes	$-1.44M
Income from Continuous Operations	$-1.44M
Consolidated Net Income/Loss	$-1.44M
Normalized Income after Taxes	$-1.44M
EBIT	$-1.12M
EBITDA	$-0.76M
Weighted-Average Shares Outstanding (Basic)	8.59M
Weighted-Average Shares Outstanding (Diluted)	8.59M
Earnings per Share (EPS) (Basic)	$-0.17
Earnings per Share (EPS) (Diluted)	$-0.17
Balance Sheet Financials
Current Assets	$23.96M
Property, Plant, and Equipment	$1.91M
Long-Term Assets	$13.14M
Total Assets	$37.10M
Current Liabilities	$18.30M
Long-Term Debt	$14.98M
Long-Term Liabilities	$16.95M
Total Liabilities	$35.26M
Common Equity	$1.84M
Tangible Shareholders Equity	$-8.34M
Shareholders Equity	$1.84M
Common Shares Outstanding	8.59M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$0.40M
Cash Flow from Investing Activities	$-0.16M
Cash Flow from Financial Activities	$-1.42M
Beginning Cash	$11.96M
End Cash	$10.78M
Increase/Decrease in Cash	$-1.18M
Stock-Based Compensation	$1.71M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.31
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.89
Debt to Equity Ratio	11.19
Gross Margin	77.25%
Operating Margin	-11.69%
EBIT Margin	-11.69%
EBITDA Margin	--
Pre-Tax Profit Margin	-14.96%
Profit Margin	-14.96%
Free Cash Flow	$0.24M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.26
Inventory Turnover	0.37
Receiveable Turnover	1.60
Days Sales in Receivables	56.14
Return on Equity	-78.29%
Return on Tangible Equity	17.25%
Return on Assets	-3.88%
Return on Investments	-8.55%
Book Value Per Share	$0.21
Free Cash Flow per Share	$0.03
Operating Cash Flow per Share	$0.05

Data from Zacks Investment Research, Inc.